These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6136400)

  • 1. [30 years of neuroleptics--time for critical discussions].
    Modestin J
    Dtsch Med Wochenschr; 1983 Sep; 108(38):1446-51. PubMed ID: 6136400
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE; Coyne L
    Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of tardive dyskinesia in long-term hospitalized schizophrenic patients].
    Rittmannsberger H; Schöny W
    Nervenarzt; 1986 Feb; 57(2):116-8. PubMed ID: 2870437
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects and complications of neuroleptics (110 hospitalizations in neurology)].
    Destee A; Montagne B; Rousseaux M; Petit H; Warot P
    Lille Med; 1980; 25(6):291-5. PubMed ID: 6105602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medicolegal aspects of tardive dyskinesia in the United States].
    Wolf MA; Grunberg F; Garneau Y
    Encephale; 1988; 14(3):133-8. PubMed ID: 2900134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary findings with regard to risk factors in the development of tardive dyskinesia [proceedings].
    Kane J; Struve F; Woerner M; Weinhold P
    Psychopharmacol Bull; 1981 Jan; 17(1):47-9. PubMed ID: 6112775
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia and depressive symptoms in schizophrenics.
    Richardson MA; Pass R; Bregman Z; Craig TJ
    Psychopharmacol Bull; 1985; 21(1):130-5. PubMed ID: 2858905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adverse effects of second generation antipsychotic agents].
    Wahlbeck K
    Duodecim; 2003; 119(19):1807-9. PubMed ID: 14601381
    [No Abstract]   [Full Text] [Related]  

  • 11. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI; Borison RL
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract]   [Full Text] [Related]  

  • 12. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G; Annable L; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
    [No Abstract]   [Full Text] [Related]  

  • 13. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic treatment with neuroleptics. I: State of research on mechanisms of action, effectiveness and compliance in treatment of psychoses].
    Krausz M; Sorgenfrei T
    Psychiatr Prax; 1991 Jan; 18(1):9-13. PubMed ID: 1674156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone-induced priapism.
    Makesar D; Thome J
    World J Biol Psychiatry; 2007; 8(1):45-7. PubMed ID: 17366350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic-related admissions to a university psychiatric clinic].
    Schmidt LG; Langscheid-Schmidt K
    Nervenarzt; 1987 Jun; 58(6):379-82. PubMed ID: 2886932
    [No Abstract]   [Full Text] [Related]  

  • 19. [Factor connected with tardive dyskinesia].
    Chouinard G; Annable L; Ross-Chouinard A
    Union Med Can; 1979 Apr; 108(4):356-73. PubMed ID: 41354
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.